We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Rejects Key Provision of Drug Safety Bill
FDA Rejects Key Provision of Drug Safety Bill
August 11, 2006
The long-awaited initiative to overhaul the nation’s drug safety efforts faces FDA opposition as agency officials say a recent legislative proposal to improve risk management plans is “unrealistic.” But at least one congressional source dismissed the criticism.